Director, Market Access & Marketing - Germany

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Role

As Genmab advances toward commercialization in Europe, this position will play a pivotal role in shaping the company’s success in the German market. The Director, Market Access (Germany) is responsible for developing and executing strategies to ensure optimal market access, reimbursement, and pricing outcomes for Genmab’s oncology portfolio. This role requires strong expertise in market access and health economics, as well as effective collaboration with regional and global teams in Medical Affairs, Regulatory Affairs, Commercial Operations, and Corporate Affairs, and engagement with HTA bodies, payers, policymakers, and key external stakeholders.

Responsibilities

Market Access & Reimbursement

• Develop, implement, and execute comprehensive German market access and reimbursement strategies for Genmab’s oncology products.
• Lead the preparation and submission of value dossiers, benefit assessments (AMNOG/G-BA), and pricing negotiations with the GKV-SV.
• Translate clinical and economic evidence into compelling value arguments tailored to the German healthcare system.
• Monitor health policy developments, HTA trends, and reimbursement landscapes to inform local access strategies.
• Collaborate closely with global and regional Market Access teams to ensure alignment with European and corporate strategies.
• Partner with Medical Affairs to ensure generation and communication of robust evidence supporting value demonstration and reimbursement success.
• Support strategic pricing decisions, budget impact analyses, and payer engagement initiatives to secure sustainable access.
• Support EU marketing on local needs in terms of materials and processes.

Health Policy, Stakeholder Engagement & External Collaboration

• Build and maintain strong relationships with payers, HTA authorities, policy influencers, and other relevant external stakeholders in Germany.
• Represent Genmab in key discussions, working groups, and policy forums relevant to access and reimbursement.
• Provide input into policy shaping and advocacy activities in close collaboration with Corporate Affairs and regional access teams.
• Gather and communicate payer insights to inform strategic planning, evidence generation, and launch readiness.

Cross-functional Collaboration

• Partner with Medical Affairs to align on evidence generation, value messaging, and payer-relevant data dissemination.
• Collaborate with Regulatory Affairs and Legal to ensure all access-related activities meet compliance and ethical standards.
• Provide local market access expertise to cross-functional brand and launch teams, contributing to forecasting, lifecycle planning, and risk mitigation.
• Represent Germany within European and global Market Access networks to ensure local needs and perspectives are reflected in global access strategies.

Requirements

• Master’s degree or higher in Life Sciences, Pharmacy, Health Economics, Public Health, or a related field.
• Minimum of 7–10 years of experience in market access, pricing, reimbursement, or health economics within the pharmaceutical or biotechnology industry.
• Proven track record managing AMNOG submissions, benefit assessments, and pricing negotiations in Germany.
• Strong understanding of the German healthcare system, HTA and payer landscape, and oncology market dynamics.
• Experience in product launches and lifecycle management for specialty or oncology medicines.
• Excellent strategic thinking, analytical, and stakeholder management abilities.
• Fluent in German and English (both written and spoken).
• Ability to work effectively in a matrixed, international environment.

Personal Attributes

• Strategic and analytical mindset with a pragmatic, hands-on approach.
• Entrepreneurial and proactive, comfortable operating in an evolving organization.
• Strong relationship builder with both internal and external stakeholders.
• Passion for improving patient access to innovative oncology therapies.

About You

• You are genuinely passionate about our purpose

• You bring precision and excellence to all that you do

• You believe in our rooted-in-science approach to problem-solving

• You are a generous collaborator who can work in teams with a broad spectrum of backgrounds

• You take pride in enabling the best work of others on the team

• You can grapple with the unknown and be innovative

• You have experience working in a fast-growing, dynamic company (or a strong desire to)

• You work hard and are not afraid to have a little fun while you do so!

Locations

Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are crafted as open, community-based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you’re in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.